Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00522171
Other study ID # CI-06-0009
Secondary ID
Status Terminated
Phase Phase 4
First received August 27, 2007
Last updated November 30, 2009
Start date September 2007
Est. completion date April 2009

Study information

Verified date November 2009
Source Ethicon Endo-Surgery
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The objective of this study is to determine if the use of The Harmonic™ (an ultrasonic surgical instrument) in Lower Body Lift procedures reduces volume and duration of wound drainage after surgery when compared to Electro Surgery.


Description:

Lower Body Lift procedures are performed to correct skin redundancy and muscle diastases caused by significant weight loss, poor skin tone, etc. Lower Body Lift procedures involve a high risk of early complications, including hematomas, seromas, necrosis, and wound-healing problems. The occurrence of these complications may be due in part to the extensive undermining and division of the superficial and the deep arterial systems, done in conventional procedures.

Persistent serous wound drainage and seromas are the most common complications in Lower Body Lift procedures. The rate of serous fluid collection determines the time drains need to remain in place. Although suction drains reduce seroma formation, prolonged use can delay healing, cause injury, and increase the risk of retrograde infection and patient discomfort. Wound drainage has a direct correlation with seroma formation. The loss of protein nutrients and minerals in the serum drained is also a concern with prolonged drainage that can result in healing delays.

The Harmonic™ technology uses ultrasonic energy that allows both cutting and coagulating at the precise point of application. The Harmonic™ has been used since 1992 predominantly in urology and gastro-intestinal surgery (laparoscopic surgery). Significantly reduced serous drainage in a number of general surgery procedures such as superficial and total parotidectomy; thyroidectomy; tonsillectomy; pectoralis major myocutaneous flap dissection; axillary dissection; and lymphadenectomy have been reported with the use of Harmonic™.

The Harmonic™ has also been used in parotidectomy and maxillofacial surgery, but its use has been seldom mentioned in the field of plastic and reconstructive surgery. Recent use of the Harmonic™ has shown promise in plastic and reconstructive surgery in dissection of the pectoralis major myocutaneous flap and total body lifts.

Comparisons: The Harmonic™ vs. Electro Surgery in Lower Body Lift procedures.


Recruitment information / eligibility

Status Terminated
Enrollment 30
Est. completion date April 2009
Est. primary completion date February 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

Subjects eligible for this clinical research study must fulfill all of the following criteria:

- Elect to undergo a Lower Body Lift procedure for post-obesity reasons;

- Able to comprehend and sign the study informed consent form;

- Able to return for all study mandated visits;

- Be a male or female greater than or equal to 18 years of age;

- Obtain medical clearance for a Lower Body Lift procedure according to institutional requirements.

Exclusion Criteria:

Subjects with any of the following criteria are not eligible to participate in this clinical research study:

- American Society Anesthesiologists (ASA) Classification of Physical Status greater than III;

- Current smoker (documented abstinence of 3 months);

- Documented current use of steroids or anti-inflammatory medications (within the past month) and no history of prolonged usage (for 1 month in the past 3 months);

- Diabetes mellitus (requiring treatment within the past year);

- Need of concomitant surgical procedures in which the wound drainage would interconnect with the wound regions studied by the trial (with the exception of liposuction);

- Presence of ventral or umbilical hernia requiring repair with the use of prosthetic material (e.g. mesh);

- Morbid obesity (Body Mass Index = 40);

- At risk for ischemia due to presence of obstruction of the arterial blood supply or inadequate blood flow;

- Presence of scars that could limit flap advancement or that could not be completely excised;

- Current diagnosis or history of any disease that would impair the healing process;

- Current diagnosis or history of immune system disorders;

- Documented history of bleeding disorders;

- Presence of uncontrolled hypertension;

- Pregnant or lactating;

- Being treated with anticoagulants including aspirin within 7 days prior to surgery (a washout period of 7 days will be required); or

- Participation in any other clinical studies within the past 30 days.

Study Design

N/A


Related Conditions & MeSH terms


Intervention

Device:
The Harmonic™ ultrasonic scalpel
A surgical instrument that uses ultrasonic energy that allows both cutting and coagulating at the precise point of application.

Locations

Country Name City State
Germany Abteilung für Plastische und Ästhetische Chirurgie Wesseling
United States Dr. Al Aly Coralville Iowa

Sponsors (1)

Lead Sponsor Collaborator
Ethicon Endo-Surgery

Countries where clinical trial is conducted

United States,  Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total Volume (mL) From the Time of Drain Placement to Time of Drain Removal From the time of drain placement to time of drain removal (</= 770 hours) No
Secondary Total Number of Hours From Drain Placement to Drain Removal From drain placement to drain removal (</= 770 hours) No
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2